BioButton Continuous Patient Monitoring System

BioIntelliSense is a US continuous health monitoring and clinical intelligence company founded in 2019 and headquartered in Golden, Colorado, with a presence in Redwood City, California. It targets the gap left by intermittent manual vital sign checks on general wards, where patient deterioration is often detected hours late.

The BioButton is a small medical-grade wearable that captures minute-level resting heart rate, resting respiratory rate, skin temperature and activity. Data passes over Bluetooth to a BioHub Wi-Fi or cellular gateway or the BioMobile app, is analysed in the cloud and shown on the BioDashboard exception management software and in the customer EMR. The same system supports in-facility monitoring and at-home transitional care. Customers are US health systems such as Houston Methodist and virtual care providers such as Hicuity Health.

• BioButton wearable: captures resting heart rate, respiratory rate, skin temperature and activity every minute.
• Multi-patient model: rechargeable, reusable FDA-cleared device with 10-day in-facility battery life.
• Flexible gateways: BioHub Wi-Fi, BioHub cellular or the BioMobile patient app.
• BioDashboard: exception management software that highlights patients showing early decline.
• EMR integration: vitals and insights flow into the hospital electronic medical record.
• Hospital-to-home: the same system continues monitoring after discharge for transitional care.

Vietnamese private hospitals could fit BioButton to post-surgical patients on general wards to flag early deterioration overnight. Hospital groups running home care services could keep monitoring discharged heart failure or post-operative patients. Elderly care facilities could use the dashboard to watch residents' vitals without frequent manual checks.

Detects deterioration earlier: a Houston Methodist study of 1,120 high-risk patients reported a 27% relative reduction in mortality risk after ICU transfer with BioButton monitoring. Lets hospitals reduce manual night-time spot checks so patients rest better and nurses focus on those who need care most. Applies in under 2 minutes, lasts 10 days in-facility and is reusable, keeping cost per monitored bed low. Supports telemetry overuse reduction, length of stay programmes and remote patient monitoring reimbursement at home.

Health systems are extending continuous monitoring beyond the ICU to general wards and into the home, driven by nursing shortages, virtual nursing models and evidence that vital sign trends predict deterioration. Hospitals in Vietnam and Southeast Asia face similar ward overcrowding and staff pressure, creating demand for low-cost wearable monitoring.

Founded in 2019, headquartered in Golden, Colorado, with an additional presence in Redwood City, California. Co-founded by CEO David Wang and Executive Chairman James Mault. The BioButton Multi-Patient wearable and BioDashboard received FDA clearance in October 2024. Partnered with Hicuity Health in February 2025; BioButton monitors more than 2,600 non-ICU beds at Houston Methodist.